A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...

Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...

Chrystal Starbird, a cancer researcher at the University of North Carolina School of Medicine, had been preparing to serve on ...

Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration ...

The University of Nebraska said it was waiting for more information about what a pause in activities at the National ...

Oregon in 2023 raked in $428 million in grants from NIH, a little less than the peak of $436 million in 2020. The agency's ...